JLPC(SH:600513) Sou Hu Cai Jing·2025-07-15 10:08Core Viewpoint - Lianhuan Pharmaceutical's stock experienced a significant drop, reaching the daily limit down on July 15, indicating potential market concerns regarding the company's performance and investor sentiment [1]. Company Overview - Lianhuan Pharmaceutical Co., Ltd. was established in December 1999, originating from Yangzhou Pharmaceutical Factory founded in 1958, and is recognized as a national high-tech enterprise engaged in research, production, and sales [1]. Shareholder Activity - Two funds under China Merchants Fund have entered the top ten shareholders of Lianhuan Pharmaceutical, holding a combined stake of 0.88%. Specifically, the China Merchants Quantitative Selected Stock A fund increased its holdings in the first quarter of this year, while the China Merchants Growth Quantitative Stock Selection A fund made a new entry [1]. - The China Merchants Quantitative Selected Stock A fund has achieved a year-to-date return of 20.03%, ranking 138 out of 992 in its category, while the China Merchants Growth Quantitative Stock Selection A fund has a year-to-date return of 15.45%, ranking 229 out of 992 [1]. Fund Performance Comparison - The performance of the China Merchants Quantitative Selected Stock A fund over various periods is as follows: - 1-week increase: 3.04% - 1-month increase: 8.72% - 3-month increase: 18.07% - 6-month increase: 21.12% - Year-to-date increase: 20.03% [2]. - In comparison, the average return of similar funds and the CSI 300 index shows lower performance, indicating that the China Merchants Quantitative Selected Stock A fund is outperforming its peers [2]. Fund Manager Profile - Wang Ping, the fund manager for both the China Merchants Quantitative Selected Stock A and the China Merchants Growth Quantitative Stock Selection A funds, has extensive experience in investment risk management and quantitative analysis, having joined China Merchants Fund in 2006 [5][6].